Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. is dedicated to realizing the potential of biologic, cell and gene therapies to offer transformative patient outcomes in areas of high unmet medical need by extending the reach of protein, cell, and gene therapies to highly prevalent neurodegenerative disorders like amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease as they are universally fatal neurodegenerative diseases.

Our vision is to build a leading gene therapy company for the treatment of neurodegenerative diseases and cancer by progressing our á-Klotho gene therapy research programs and identifying, developing, and commercializing other novel gene therapy treatments and in vitro diagnostics for neurodegenerative diseases, cancer and other age-related pathologies.